Company news

Shanghai Kaikai Industrial Co., Ltd. news in 2026

Shanghai Kaikai Industrial Co., Ltd.'s news releases, calls and decks from 2026, newest first.

View company

(600272)"Shanghai Kai Kai Industrial Company Limited"Announcement on Use of Idle Self-owned Funds to Purchase Bank Wealth Management Products

November 6, 2026

(600272)"Shanghai Kai Kai Industrial Company Limited"Report for Q3 2026

October 29, 2026

(600272)"Shanghai Kai Kai Industrial Company Limited"Announcement on Resolutions of the 6th Meeting of the 11th Board of Directors

October 29, 2026

(600272)"Shanghai Kai Kai Industrial Company Limited"Announcement on Key Operating Data for the First Three Quarters of 2026

October 29, 2026

(600272)"Shanghai Kai Kai Industrial Company Limited"Announcement on Use of Idle Self-owned Funds to Purchase Bank Wealth Management Products

October 23, 2026

Announcement on Use of Idle Self-owned Funds to Purchase Bank Wealth Management Products

September 28, 2026

Announcement on Resolutions of the 1st Extraordinary General Meeting in 2026

September 18, 2026

Announcement on Participation in and Summary of the 2026 Collective Reception Day for Listed Companies in Shanghai Jurisdiction and Interim Performance Briefing

September 16, 2026

Indicative Announcement on Convening the 1st Extraordinary General Meeting in 2026

September 10, 2026

Announcement on Change of Non-independent Director

August 28, 2026

Announcement on Abnormal Fluctuations in Stock Trading and Risk Warning

August 18, 2026

Announcement on Risk Warning in Stock Trading

August 11, 2026

Announcement on Abnormal Fluctuations in Stock Trading

August 10, 2026

Announcement on Progress of Authorizing the Wholly-owned Subsidiary, Shanghai Leiyunshang Pharmaceutical West Co., Ltd., to Acquire the Minority Equity Interest in Its Controlled Subsidiary, Shanghai Leixi Jingyi Supply Chain Management Co., Ltd.

August 6, 2026

Announcement on Using Idle Self-owned Funds to Purchase Bank Financial Products

July 31, 2026

Announcement on the Authorization of the Wholly-Owned Subsidiary, SHANGHAI LEIYUNSHANG PHARMACEUTICAL CO,. LTD., to Acquire the Minority Equity Interest in Its Controlled Subsidiary, Shanghai Leixi Jingyi Supply Chain Management Co., Ltd.

July 17, 2026

Announcement on Expected Increase in Semi-annual Performance for 2026

July 14, 2026

Announcement on Implementation of Dividend Distribution for 2025

June 29, 2026

Announcement on Completion of Capital Increase to Wholly-owned Subsidiary Shanghai Leiyunshang Pharmaceutical West District Co., Ltd.

June 12, 2026

Announcement on Resolutions of the 2025 Annual General Meeting

June 5, 2026

Indicative Announcement on Convening the 2025 Annual General Meeting

May 29, 2026

Announcement on Progress in Capital Increase to Wholly-owned Subsidiary Shanghai Leiyunshang Pharmaceutical West District Co., Ltd.

May 15, 2026

Announcement on Attending Annual Report Collective Performance Briefing of Listed Companies in Shanghai Jurisdiction in 2026

May 7, 2026

Notice on Convening the 2025 Annual General Meeting

April 29, 2026

Announcement on Actual Amount Incurred in Daily Related Party Transactions in 2025 and Daily Related Party Transactions in 2026

March 27, 2026

Announcement on Using Idle Self-owned Funds to Purchase Bank Financial Products

March 24, 2026

Announcement on Completion of Transfer of 11.11% Equity in Nanjing Tianshi Software Technology Co., Ltd.

February 12, 2026

Announcement on Cancellation of Special Accounts for Raised Funds

January 29, 2026

Announcement on Expected Decrease in Performance for 2025

January 23, 2026

Announcement on Progress in Transfer of 11.11% Equity in Nanjing Tianshi Software Technology Co., Ltd.

January 13, 2026